Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Lymphoma

Free Subscription 13.04.2026 1 Am J Clin Pathol 1 Am J Hematol 2 Blood 1 Br J Haematol 2 Cancer 1 Eur J Haematol 2 Haematologica 1 Int J Cancer 1 J Natl Cancer Inst 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. KARUBE K
   Highly sensitive HBZ RNA in situ hybridization enables routine pathologic diagnosis of adult T-cell leukemia/lymphoma.
   Am J Clin Pathol. 2026;165:aqag022.
   PubMed        
   
   

   
   Am J Hematol

2. TRABOLSI A, Keenan J, Isrow D, Chui M, et al
   Combination of Ocular Radiation With Systemic Chemotherapy for Treatment of Primary Vitreoretinal Lymphoma: A Prospective Single Center Cohort With Long Follow-Up.
   Am J Hematol. 2026 Apr 10. doi: 10.1002/ajh.70320.
   PubMed        
   
   

   
   Blood

3. AOKI T, Kuruvilla J
   Targeted therapy in early-stage classical Hodgkin lymphoma.
   Blood. 2026;147:1655-1657.
   PubMed        
   
   
4. SCHROERS-MARTIN JG
   Digging deep for the roots of lymphoma.
   Blood. 2026;147:1657-1658.
   PubMed        
   
   

   
   Br J Haematol

5. MARTYNCHYK A, Chong G, Khor R, Lee D, et al
   Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naive follicular lymphoma: Results from the phase II 'FLUORO' study.
   Br J Haematol. 2026 Apr 8. doi: 10.1111/bjh.70468.
   PubMed         Abstract available
   
   

   
   Cancer

6. DANILOV AV, Coombs CC, Phillips T, Allan JN, et al
   Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.
   Cancer. 2026;132:e70389.
   PubMed         Abstract available
   
   
7. SUZUKI K, Miyazaki K, Asano N, Takahashi H, et al
   Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.
   Cancer. 2026;132:e70390.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

8. BONELLO F, Aroldi A, Castellino A, Mannelli L, et al
   Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience.
   Eur J Haematol. 2026 Apr 6. doi: 10.1111/ejh.70183.
   PubMed         Abstract available
   
   

   
   Haematologica

9. POTT C
   Relapse as a return, not a reinvention - genomic stability and pre-existing resistance in mantle cell lymphoma.
   Haematologica. 2026 Apr 9. doi: 10.3324/haematol.2025.289129.
   PubMed         Abstract available
   
   
10. ANDRE A, Bourbon E, Cartron G, Morschhauser F, et al
    Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA study.
    Haematologica. 2026 Apr 9. doi: 10.3324/haematol.2025.289196.
    PubMed         Abstract available
    
    

    
    Int J Cancer

11. HIRABAYASHI M, Georges D, Combes JD, Clifford GM, et al
    Attributable Fraction of Epstein-Barr Virus in Subtypes of Lymphoma: A Systematic Review and Global Meta-Analysis.
    Int J Cancer. 2026 Apr 7. doi: 10.1002/ijc.70468.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

12. ROSHANI S, Boekel NB, Van Leeuwen FE, Rademakers SE, et al
    Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.
    J Natl Cancer Inst. 2026 Mar 23:djag090. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    PLoS One

13. 
    Expression of Concern: Trends and disparities in Non-Hodgkin Lymphoma related mortality in the United States, 1999-2020.
    PLoS One. 2026;21:e0346387.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum